Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lisa Nowinski, Ph.D.

Concepts (73)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Lisa Nowinski's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Lisa Nowinski has written about over time.
Rorschach Test, 1 publications between 2010 and 2010, average publication date April 2010. Stress, Psychological, 1 publications between 2010 and 2010, average publication date April 2010. Child Language, 1 publications between 2017 and 2017, average publication date January 2017. Communication Disorders, 1 publications between 2017 and 2017, average publication date January 2017. Interpersonal Relations, 2 publications between 2017 and 2020, average publication date August 2018. Counseling, 1 publications between 2018 and 2018, average publication date November 2018. Buspirone, 1 publications between 2019 and 2019, average publication date March 2019. Communication, 2 publications between 2018 and 2019, average publication date May 2019. Autistic Disorder, 3 publications between 2014 and 2023, average publication date November 2019. Angelman Syndrome, 2 publications between 2019 and 2021, average publication date June 2020. Social Behavior, 2 publications between 2020 and 2021, average publication date January 2021. Oxytocin, 2 publications between 2021 and 2023, average publication date May 2022. Receptors, GABA, 1 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Nowinski's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.